Drug Utilization Review on a Tertiary Palliative Care Unit

Journal of Pain and Symptom Management

Volumn 31, Issue 5, 2006, Pages 457-464

  Llanes, Lea Renina ^a   Fassbender, Konrad ^a   Baracos, Vickie E ^a   Watanabe, Sharon ^a  

^a Division of Palliative Care Medicine   (Canada)

Author keywords

Drug utilization review; fentanyl; ondansetron; palliative care unit; total parenteral nutrition

Indexed keywords

CODEINE; DEXAMETHASONE; FENTANYL; HYDROMORPHONE; METHADONE; METHYLPREDNISOLONE; METOCLOPRAMIDE; MORPHINE; ONDANSETRON; OPIATE; OXYCODONE; PLACEBO;

ARTICLE; CANCER PAIN; CLINICAL TRIAL; CONSULTATION; DEMOGRAPHY; DRUG COST; DRUG INDICATION; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; HOSPITAL ADMISSION; HOSPITAL SUBDIVISIONS AND COMPONENTS; HUMAN; KIDNEY FAILURE; NAUSEA AND VOMITING; PALLIATIVE THERAPY; PATIENT SATISFACTION; PRESCRIPTION; RETROSPECTIVE STUDY; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTI-ANXIETY AGENTS; COST-BENEFIT ANALYSIS; DRUG UTILIZATION REVIEW; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ONDANSETRON; PAIN; PALLIATIVE CARE; PARENTERAL NUTRITION, TOTAL;

EID: 33646720080     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2005.08.017     Document Type: Article

References (27)

1. Mangione-Smith R., Elliott M.N., McDonald L., and McGlynn E.A. An observational study of antibiotic prescribing behavior and the Hawthorne effect. Health Serv Res 37 (2002) 1603-1623
2. Hanks G.W., deConno F., Cherny N., et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Expert Working Group of the Research Network of the European Association for Palliative Care. Br J Cancer 84 (2001) 587-593
3. Payne R., Chandler S., and Einhaus M. Guidelines for the clinical use of transdermal fentanyl. Anticancer Drugs 6 (1995) 50-53
4. Paix A., Coleman A., Lees J., et al. Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain 63 (1995) 263-269
5. Watanabe S., Pereira J., Hanson J., and Bruera E. Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study. J Pain Symptom Manage 16 (1998) 323-326
6. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 28 (2004) 497-504
7. Mercadante S., Caligara M., Sapio M., Serretta R., and Lodi F. Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure. J Pain Symptom Manage 13 (1997) 241-244
8. Zeppetella G. Sublingual fentanyl citrate for cancer-related breakthrough pain: a pilot study. Palliat Med 15 (2001) 323-328
9. Gralla R.J., Osoba D., Kris M.G., et al. Recommendations for the use of antiemetics: evidence-based clinical practice guidelines. J Clin Oncol 17 (1999) 2971-2994
10. Bruera E., Belzile M., Neumann C., et al. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19 (2000) 427-435
11. Popiela T., Lucchi R., Giongo F., and the Methylprednisolone Female Preterminal Cancer Study Group. Methylprednisolone as palliative therapy for female terminal cancer patients. Eur J Cancer Clin Oncol 25 (1989) 1823-1829
12. Bruera E., Seifert L., Watanabe S., et al. Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage 11 (1996) 147-153
13. Hardy J., Daly S., McQuade B., et al. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Support Care Cancer 10 (2002) 231-236
14. Weiss S.M., Worthington P.H., Prioleau M., and Rosato F.E. Home total parenteral nutrition in cancer patients. Cancer 50 (1982) 1210-1213
15. Ripamonti C., Twycross R., Baines M., et al. Working Group of the European Association for Palliative Care. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 9 (2001) 223-233
16. Bozzetti F., Cozzaglio L., Biganzoli E., et al. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr 21 (2002) 281-288
17. Lundholm K., Daneryd P., Bosaeus I., Korner U., and Lindholm E. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 100 (2004) 1967-1977
18. Van Gossum A., Bakker H., Bozzetti F., et al. Home parenteral nutrition in adults: a European multicentre survey in 1997. ESPEN-Home Artificial Nutrition Working Group. Clin Nutr 18 (1999) 135-140. http://palliative.org Home Parenteral Nutrition and Cancer-Selection Criteria for Patients with Advanced Cancer. From Clinical Practice Guidelines. Regional Palliative Care Program in Edmonton, Alberta. http://palliative.org. Accessed March 2, 2006
19. McKinlay A.W. Nutritional support in patients with advanced cancer: permission to fall out?. Proc Nutr Soc 63 (2004) 431-435
20. Home Parenteral Nutrition and Cancer-Selection Criteria for Patients with Advanced Cancer. Clinical Practice Guidelines. Regional Palliative Care Program in Edmonton, Alberta, Canada. http://palliative.org. Accessed March 2, 2006.
21. Bruera E., Schoeller T., Wenk R., et al. A prospective multicenter assessment of the Edmonton Staging System for cancer pain. J Pain Symptom Manage 10 (1995) 348-355
22. Anderson F., Downing G.M., Hill J., et al. Palliative Performance Scale (PPS): a new tool. J Palliat Care 12 (1996) 5-11
23. Bruera E., Kuehn N., Miller M.J., Selmser P., and Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7 (1991) 6-9
24. Hoda D., Jatoi A., Burnes J., et al. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition?. Cancer 103 (2005) 863-868
25. Ferris F.D., Balfour H.M., Bowen K., et al. A model to guide hospice palliative care (2002), Canadian Hospice Palliative Care Association, Ottawa, ON
26. Bechel D.L., Myers W.A., and Smith D.G. Does patient-centered care pay off?. Jt Comm J Qual Improv 26 7 (2000) 400-409
27. Downie J. Unilateral withholding and withdrawal of potentially life-sustaining treatment: a violation of dignity under the law in Canada. J Palliat Care 20 (2004) 143-149